COVID-19 pandemic
The National Medical Products Administration grants conditional approval for a single-dose vaccine made by CanSino Biologics and a vaccine made by Sinopharm.
Sources: ABC News
Changes
- The National Medical Products Administration grants a conditional approval of one vaccine made by CanSino Biologics, which only requires single-shot, and another made by Sinopharm for public use.
- The National Medical Products Administration grants conditional approval for a single-dose vaccine made by CanSino Biologics and a vaccine made by Sinopharm.